A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

A breakthrough deal to attempt to limit global temperature rises was agreed at a conference of world nations in December 2015. These charts from the time show how and why the Earth’s climate is ...